Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd. (“Polyrizon”), a privately held company in which Medigus owns 37.03%, has submitted a PCT (Patent Cooperation Treaty) application, following a submission to the United States Patent and Trademark Office for its innovative technology.
Novavax Starts COVID-19, Flu Combination Vaccine Trial
Novavax Inc (NASDAQ:NVAX) has enrolled the first participants in a Phase 1/2 study to test its combined flu and COVID-19 vaccine.…
